Business NewsFeaturedRadical Consumerist

Elevai Labs Unveils New Paradigm Shifting Skincare Technology at Global Aesthetics Conference in Miami, Florida

At the Conference, Elevai Labs Co-Founder and CEO Jordan R. Plews, Ph.D. Will Be Giving a Scientific Presentation on the Key Considerations For an Emerging New Class of Regenerative Skincare

Elevai Labs, a medical aesthetic biotechnology company specializing in regenerative skincare, announces its sponsorship and participation in the upcoming Global Aesthetics Conference on November 3-5 in Miami.

The Future of Skincare is Now

A new era is upon us when it comes to regenerative skincare. Co-founder and Chief Executive Officer of ELEVAI Skincare, Jordan R. Plews, Ph.D., is presenting on the proprietary ELEVAI Exosome Technology™, detailing why the exosome source is a key consideration. ELEVAI’s unique targeted approach to stem cell exosome technology continues to advance the way we think about and use topical formulations both for post-procedure and daily skincare applications.

Join ELEVAI at 3:30 PM on Thursday, November 3, for Dr. Plews’ scientific presentation and a live microneedling demonstration to demonstrate the use of ELEVAI’s award-winning E-Series™ post-procedure exosome products. Look for “ELEVAI EXOSOME TECHNOLOGY™, A PARADIGM SHIFT IN TOPICAL POST-PROCEDURE SKINCARE” on the agenda. You will not want to miss this!

Dr. Plews is a Stanford-trained scientist with a background in biochemical engineering and stem cell research that co-founded ELEVAI to solve unmet needs in the regenerative aesthetics skincare space. His years in the field and academics have informed the innovative technology, formulations, ingredient selection, and a vertically integrated lab – all elements which are essential to ELEVAI’s efficacious and science-driven skin care product line.

Source: Global Aesthetics Conference

???? Kicks Off Coverage of the Emerging and Recession Resilient Cosmeceuticals Industry

While Getting Older Is Inevitable, Skin Aging Does Not Have to Be

Patent-pending ELEVAI Exosomes™ are the powerhouse ingredient in all ELEVAI products, mimicking the elegant repair processes of nature and paired with a selection of high-quality science-backed actives to provide regenerative skin health for any skin type.

“By employing ethically sourced stem cells, ELEVAI can harness the power of Human Umbilical Mesenchymal Stem Cells (hUMSC) and, in proprietary conditions, capture the released exosomes and carefully filter the concentrate to produce ELEVAI exosomes,” shares Dr. Plews of the brand’s breakthrough process. The nanosize of the exosomes allows ELEVAI products to penetrate deep into the skin for repair and rejuvenation.

For those attending the Global Aesthetics Conference, Elevai Labs invites you to visit the company at booth #517 to learn more. View the floor plan of the 2022 Global Aesthetics Conference here.

For more information, visit the Elevai Skincare website here.

Interested in buying Elevai Skincare products? Click here to find an authorized Elevai Skincare Professional.

View the original Elevai Labs press release here.

Elevai Labs has set the stage with its new products, and we’ll be watching as the company makes inroads into the physician-dispensed market.

Wealthy VC will be releasing an in-depth, 15-page report on Elevai Labs as well as interviewing the company’s CEO in the coming weeks.

Be one of the first to receive the report by Subscribing to Our Email Newsletter via the sign-up box below.

Also, please consider Following Us on Social Media via the Wealthy VC social links below to stay up to date on Elevai Labs.

Follow Wealthy VC on Social Media: Facebook | Instagram | Twitter | LinkedIn | GETTR

????Join the Discussion in the Wealthy VC Investor Group

????Have a Stock Tip or New  Story Suggestion? Email us at

Elevai Labs Inc. is a paid client of Wealthy VC.

Wealthy VC’s parent company has been compensated $13,500 per month for 12 months for investor relations, public relations, and market awareness services by Elevai Labs Inc.

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.

View Full Disclaimer Here

Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC and TCI. Ryan has 15+ years of investing experience. Twitter | Email

Related Articles

Back to top button